|
Originally published In Press as doi:10.1074/jbc.M107080200 on September 6, 2001
J. Biol. Chem., Vol. 276, Issue 45, 41782-41789, November 9, 2001
The Sorting Nexin, DSH3PX1, Connects the Axonal Guidance
Receptor, Dscam, to the Actin Cytoskeleton*
Carolyn A.
Worby,
Nancy
Simonson-Leff,
James C.
Clemens ,
Robert
P.
Kruger,
Marco
Muda§, and
Jack E.
Dixon¶
From the Life Sciences Institute and the Department of Biological
Chemistry, University of Michigan Medical School,
Ann Arbor, Michigan 48109-0606
Received for publication, July 25, 2001, and in revised form, September 6, 2001
 |
ABSTRACT |
Dock, an adaptor protein that functions in
Drosophila axonal guidance, consists of three tandem Src
homology 3 (SH3) domains preceding an SH2 domain. To develop a better
understanding of axonal guidance at the molecular level, we used the
SH2 domain of Dock to purify a protein complex from fly S2 cells. Five
proteins were obtained in pure form from this protein complex. The
largest protein in the complex was identified as Dscam
(Down syndrome cell
adhesion molecule), which was subsequently
shown to play a key role in directing neurons of the fly embryo to
correct positions within the nervous system (Schmucker, D., Clemens,
J. C., Shu, H., Worby, C. A., Xiao, J., Muda, M., Dixon,
J. E., and Zipursky, S. L. (2000) Cell 101, 671-684). The smallest protein in this complex (p63) has now been
identified. We have named p63 DSH3PX1 because it appears to be the
Drosophila orthologue of the human protein known as SH3PX1.
DSH3PX1 is comprised of an NH2-terminal SH3 domain, an
internal PHOX homology (PX) domain, and a carboxyl-terminal coiled-coil region. Because of its PX domain, DSH3PX1 is considered to
be a member of a growing family of proteins known collectively as
sorting nexins, some of which have been shown to be involved in
vesicular trafficking. We demonstrate that DSH3PX1 immunoprecipitates with Dock and Dscam from S2 cell extracts. The domains responsible for
the in vitro interaction between DSH3PX1 and Dock were also identified. We further show that DSH3PX1 interacts with the
Drosophila orthologue of Wasp, a protein component of actin
polymerization machinery, and that DSH3PX1 co-immunoprecipitates with
AP-50, the clathrin-coat adapter protein. This evidence places DSH3PX1 in a complex linking cell surface receptors like Dscam to proteins involved in cytoskeletal rearrangements and/or receptor trafficking.
 |
INTRODUCTION |
Axon guidance is a form of cell movement in which the cell body
remains stationary while a specialized structure at the tip of the
axon, known as the growth cone, receives signals from the environment
and translates these signals into directed neurite outgrowth (reviewed
in Ref. 1). Growth cone movement is accomplished via adhesion molecules
that modulate attachment to the extracellular matrix and neighboring
cells (2, 3). In addition, growth cones express guidance receptors
responsive to extracellular ligands that convey attractive or repulsive
signals, thereby specifying the direction of growth (4). Although a
number of guidance receptors have been reported, the mechanisms by
which these receptors coordinate changes in the actin cytoskeleton of
the growth cone are not well understood.
Several years ago, a genetic screen designed to find genes important in
axonal guidance identified a Drosophila protein known as
Dock that was essential for the guidance of photoreceptor axons in
third instar larva (5). Dock contains three tandem
SH31 domains and a single SH2
domain and is the fly orthologue of the mammalian protein, Nck. Using
an epitope-tagged SH2 domain of Dock, we recently isolated a novel
receptor-like molecule known as Dscam, the Drosophila
orthologue of the human Down's syndrome cell adhesion molecule
(DSCAM), which is essential for guidance of embryonic axons within
Bolwig's nerve and elsewhere in the developing nervous system of the
fly (6). Dscam was one of five proteins found in the complex isolated
using the Dock epitope-tagged SH2 domain. We have now identified and
characterized the smallest protein in this complex, p63. We have named
p63, DSH3PX1, because it appears to be the Drosophila
orthologue of the human protein known as SH3PX1. DSH3PX1 contains an
SH3 domain, a PHOX homology (PX) domain, and a coiled-coil domain. The
PX and coiled-coil domains are found in a number of proteins involved
in vesicular trafficking including members of the sorting nexin family
(7-9). One of the earliest identified sorting nexins, SNX1, was
isolated based on its ability to bind to the cytoplasmic domain of the epidermal growth factor receptor and to enhance degradation of ligand-activated receptors (8). The PX domain is a conserved stretch of
~130 amino acids of unknown function, first identified in the
p40phox and p47phox subunits of the NADPH
oxidase complex (10). PX domain-containing proteins belong to a large
family of hydrophilic molecules, most of which are found partially
associated with cellular membranes. Recently, the NMR solution
structure for the PX domain of p47phox was determined (11). In
addition, the p47phox PX domain and others, including the PX
domain of sorting nexin SNX3, were also shown to mediate binding to
phosphoinositides, thereby targeting these proteins to cellular
membranes (12, 13).
Using a two-hybrid screen employing DSH3PX1, we demonstrate that this
putative sorting nexin interacts directly with the Wiskott-Aldrich syndrome protein (Wasp). Members of the Wasp family are multidomain proteins that serve as scaffolds, bringing together components of
signal transduction pathways with cellular machinery that promote actin
polymerization and microfilament reorganization (14-16). Execution of
this program then leads to formation of protrusive, actin-based
membrane structures at the cell surface. When activated by Cdc42 and
phosphatidylinositol 4,5-bisphosphate, the Wasp homologue, N-Wasp,
induces long actin microspike formation (17). Recently Nck and
phosphatidylinositol 4,5-bisphosphate have been shown to
synergistically activate actin polymerization through N-Wasp in an
in vitro actin pyrene assay (18). N-Wasp has also been shown
to be essential in nerve growth factor-stimulated neurite extension in
PC12 cells, presumably through Arp2/3 complex-induced actin
polymerization (19). Wasp's ability to promote the polymerization of
actin has also been implicated in endocytosis (20). Ligand-activated epidermal growth factor receptor was found associated with N-Wasp (21),
and lymphocytes from Wasp knockout mice exhibited both a reduction in
actin polymerization and defects in T cell receptor endocytosis (22).
Endocytosis of cell surface receptors often involves clathrin-coated
pits, which are composed of a clathrin lattice and the AP2 protein
complex (23, 24). Interestingly, we demonstrated that DSH3PX1
co-immunoprecipitated with AP-50, one of the clathrin coat adaptor
proteins also known as µ2 (25). Collectively, our results suggest
that DSH3PX1 links Dscam signaling to Wasp, a protein capable of
modulating the actin cytoskeleton, and that this activity may serve to
regulate the intracellular trafficking of Dscam.
 |
MATERIALS AND METHODS |
S2 Cell Culture, Transfections, and RNA Interference
(RNAi)--
Schneider 2 (S2) cells were grown in Schneider
Drosophila medium (Life Technologies, Inc.) supplemented
with 10% fetal bovine serum, 50 units/ml penicillin, and 50 µg/ml
streptomycin in 75-cm2 cell culture flasks (Corning) at
room temperature.
S2 cells were transfected with the Drosophila expression
vector, pAC5.1/V5-His (Invitrogen), containing the coding sequences for
Wasp and AP-50, using Fugene (Roche Molecular Biochemicals) with the
following protocol. 6 × 106 cells were plated onto a
100-mm dish and allowed to attach for at least 3 h. 32 µl of
Fugene was added to 800 µl of Dulbecco's modified Eagle's medium
and mixed gently by inversion followed by a 5-min incubation period,
after which 16 µg of DNA was added, followed by an additional 20-min
incubation. This mixture was gently layered over the cells, which were
incubated an additional 48-72 h. Stable transformants were selected
using the aforementioned S2 growth medium containing 200 µg/ml
Hygromycin B (Roche Molecular Biochemicals).
RNAi experiments were conducted as described previously (26). A
detailed protocol has also been recently published (27). Briefly, S2
cells were diluted to 1 × 106 cells/ml in serum-free
DES medium (Invitrogen) with 2 mM glutamine. Typically, 1 ml of the cell suspension is added to one well of a six-well culture
dish (Corning). 15 µg of double-stranded RNA corresponding to the
protein of interest were then added to each well. 2 ml of Schneider
Drosophila medium containing 10% fetal bovine serum were
added after 30 min. Cells were harvested 4 days after treatment. The
procedure was scaled to suit the needs of particular experiments.
Primers used to create the PCR template for double-stranded RNA
production incorporate the T7 promoter 5' to the gene-specific sequences. Primer sequences used to make PCR templates are as follows:
DSH3PX1, GenBankTM accession number AF223381, sense primer
1124-1139, antisense primer 1749-1765; Dock, accession number U57816,
sense primer 1544-1564, antisense primer 2200-2181; Wasp, FlyBase ID
FBgn0024273 predicted cDNA, sense primer 204-221, antisense primer
823-808.
Antibody Affinity Purification, Co-immunoprecipitation, and
Western Analysis--
Polyclonal antisera were raised in rabbits
against recombinant fusion proteins for Dock, DSH3PX1, and Dscam
(Cocalico, Reamstown, PA). The Tyr(P) antibody (4G10) and V5
epitope antibody were purchased from Upstate Biotechnology, Inc., and
Invitrogen, respectively. Affinity columns for purification of antisera
were produced by coupling the appropriate recombinant fusion protein to
an Affi-Gel support (Bio-Rad) according to the protocol supplied by the
manufacturer. Eluted fractions containing antibody were combined and
concentrated in 1× phosphate-buffered saline using a Centricon Plus 20 centrifugal filtration device (Millipore Corp.).
For immunoprecipitations, cell extracts were made from ~1 × 107 Schneider 2 cells. Cells were collected by
centrifugation and lysed by repeated passage through a 25-gauge
needle in 1 ml of RIPA buffer (50 mM Tris, pH 8.0, 150 mM NaCl, 1% Nonidet P-40, 0.5% deoxycholate, 0.1%
SDS, 0.2 mM sodium vanadate, 10 mM NaF, 0.4 mM EDTA, 10% glycerol) containing protease inhibitors.
Extracts were cleared by ultracentrifugation at 107,000 × g for 30 min at 4 °C. 3 µl of affinity-purified
antibody were added to 450 µl of extract supernatant and incubated at
4 °C on a rocker platform. After 1 h, 50 µl of Protein
A-agarose (Life Technologies, Inc.) were added to bind immune
complexes. Following an additional 1 h of incubation on the rocker
platform at 4 °C, samples were washed four times with RIPA buffer,
resuspended in 50 µl of Laemmli loading buffer, and stored frozen at
20 °C.
For Western analysis, 10-µl samples were electrophoresed on
SDS-polyacrylamide gels and transferred to Immobilon-P (Millipore) at
100-105 V for 1 h in transfer buffer (12 mM Tris
base, 96 mM glycine, 20% methanol) cooled to 20 °C.
Affinity-purified antibodies were used at the following dilutions:
anti-DSH3PX1 (1:5000), anti-Dock (1:1000), anti-Dscam (1:1000),
anti-Tyr(P) (1:5000), and anti-V5 (1:1000). All antibodies were
diluted in blotting solution consisting of Tris-buffered saline with
5% dried milk and 0.1% Tween or consisting of 4% ovalbumin and 0.2%
Tween for 4G10 Westerns. Either goat anti-rabbit IgG or goat anti-mouse
IgG horseradish peroxidase-linked secondary antibody (1:3000) from
Bio-Rad was used where appropriate. HRPL reagents (National
Diagnostics) were used to detect immunoreactive proteins by
chemiluminescence. Blots were exposed to Biomax MR film (Eastman Kodak
Co.).
GST-Dock in Vitro Pull-down Assay--
S2 cell extract was
prepared by lysing 8 × 107 cells in 4 ml of RIPA
buffer as described above.
GST-tagged proteins for each of Dock's 3 SH3 domains and its SH2
domain were expressed in bacteria and purified on glutathione agarose
(28). 1 ml of S2 extract was mixed with 10 µg of protein attached to
beads, incubated for 1 h at 4 °C with rocking, washed three
times with RIPA (1 ml each), and resuspended in 50 µl of Laemmli
loading buffer. 5 µl were analyzed on a 10% SDS-polyacrylamide gel
and Western blotted using antibodies directed against DSH3PX1.
Two-hybrid Screens--
Full-length DSH3PX1 was fused in-frame
into pLexAde and transfected into the L40 yeast strain. These cells
were then transfected with a pACT Drosophila third instar
larva cDNA library (Stephen J. Elledge, Baylor College of Medicine
(29)), and positive colonies were isolated as described (30). Briefly,
11 million transformants were assayed for a positive two-hybrid
interaction on histidine-deficient plates, followed by confirmation
with a -galactosidase filter assay. The bait plasmid was selectively
removed, aided by ADE selection (30), and pACT fusions were isolated
and sequenced. The -galactosidase assay was scored as follows: blue
color apparent by 15 min (+++), blue color apparent by 30 min (++),
blue color apparent by 45 min (+), and either no blue color apparent or
blue color apparent after 1 h ( ).
 |
RESULTS |
DSH3PX1 Interacts with Dock--
To identify
tyrosine-phosphorylated proteins that are capable of interacting with
Dock, a hexahistidine-tagged Dock-SH2 domain was stably expressed in S2
cells (S2HisSH2). The overexpression of Dock-SH2 domain in
these cells leads to the accumulation of specific
tyrosine-phosphorylated proteins. This is presumably because the SH2
domain protects these phosphorylated proteins from endogenous tyrosine
phosphatases. Proteins complexed to the epitope-tagged SH2 domain of
Dock were purified by nickel-agarose affinity chromatography and
visualized by Western analysis using anti-phosphotyrosine antibodies
(4G10) (Fig. 1A,
left panel). The eluate from the nickel column
was further purified by 4G10 affinity chromatography (6). Elution of
the proteins from this column, subsequent separation by SDS-PAGE, and
visualization by Coomassie staining resulted in the recovery of five
protein bands (Fig. 1A, right panel).
The band designated p63 was excised from the gel and digested with
trypsin, and the peptides were separated by high pressure liquid
chromatography. Sequence analysis of the tryptic peptides provided five
unambiguous amino acid sequences (underlined in Fig.
1B) that were used to search the Berkeley Drosophila Genome data base for corresponding expressed
sequence tags. One expressed sequence tag, LD17205, was sequenced in
its entirety, and it encoded the full-length protein sequence shown in
Fig. 1B. All of the predicted peptides obtained for p63 were encoded in expressed sequence tag LD17205. p63 contained two well conserved domains, an NH2-terminal SH3 domain
(gray shading) and an internal PX domain
(black shading). In addition, the last 20 amino
acids are predicted to form a coiled-coil structure (clear box, Fig. 1C) (31). p63 contains two proline-rich
(pxxp) motifs which could serve as binding sites for SH3
domains. The first is present at amino acid 86 and the second is
contained within the PX domain at amino acid 274 (Fig.
1B, gray boxes) (10). The presence of a PX domain
places p63 in the growing family of hydrophilic membrane-associated
sorting nexins believed to be involved in vesicular trafficking and
targeting (8, 9, 32). The presence of the SH3 domain is uncommon for
sorting nexins, but it is found in human sorting nexin 9 (SNX9), also
known as SH3PX1 (33). Sequence alignment of p63 with human and
Caenorhabditis elegans orthologues shows a high degree of
identity, especially in the SH3 and PX domains (Fig.
2). Furthermore, the proline-rich sequence found in the PX domain is conserved among these species, while
the PXXP motif present at amino acid 86 is not conserved in
the human orthologue (Fig. 2). Based on the similar domain arrangement
and high degree of identity, we named Drosophila p63 DSH3PX1.

View larger version (36K):
[in this window]
[in a new window]
|
Fig. 1.
Isolation and characterization of p63.
A, purification of Tyr(P) (pTyr)-containing
proteins. Tyrosine-phosphorylated proteins were purified from S2 cell
extracts prepared from cells overexpressing the hexahistadine-tagged
SH2 domain of Dock by binding first to nickel-agarose followed by a
4G10 affinity column. The proteins eluted from the nickel-agarose
column were visualized by Western analysis using anti-Tyr(P), and the
proteins eluted from the 4G10 column were visualized by SDS-PAGE and
Coomassie staining. Coomassie-stained proteins were excised,
trypsin-treated, and microsequenced. B, amino acid sequence
of p63. p63 is the Drosophila orthologue of human SH3PX1,
henceforth DSH3PX1. DSH3PX1 consists of an SH3 domain
(shaded gray) and a PX domain (shaded
black). The penultimate 20 amino acids are predicted to form
a coiled-coil (clear box). The PXXP
motifs are boxed. The amino acid sequences obtained for the
p63 tryptic peptides are underlined. C, schematic
representation of DSH3PX1. Domain predictions were generated by the
programs SMART (52) and Coils (31).
|
|

View larger version (89K):
[in this window]
[in a new window]
|
Fig. 2.
Amino acid sequence alignments for DSH3PX1
orthologues. Alignments of the amino acid sequences for
Drosophila, human, and C. elegans SH3PX1.
Dark shading represents sequence identity, and
light shading represents sequence
similarity.
|
|
Since DSH3PX1 had been purified using the SH2 domain of Dock, we
thought it was important to demonstrate that the two molecules associate with one another in vivo. Fig.
3A shows that DSH3PX1 co-immunoprecipitates with Dock from S2 cell extracts. However, only a
fraction of the endogenous DSH3PX1 is tyrosine-phosphorylated, and it
is this form of the protein that is preferentially
co-immunoprecipitated by Dock-specific antibodies, as is evident from
Fig. 3B. The most obvious conclusion to draw from these
results is that Dock's SH2 domain mediates the association with
DSH3PX1-pY. However, since DSH3PX1 also contains two PXXP
motifs, it is conceivable that the Dock SH3 domains could also
participate in the observed protein-protein interaction. To better
define the binding of DSH3PX1 and Dock, GST fusions of the three SH3
domains and the SH2 domain of Dock were isolated from bacteria and used
in an in vitro pull-down assay. Protein extracts were
prepared from S2 cells, and pull-down assays using the GST fusion
proteins are shown in Fig. 3C. In S2 cell extracts, the
SH3.3 domain is able to interact weakly with DSH3PX1 either alone or in
the context of SH3 domains 1-3. However, the principal interaction
between DSH3PX1 and Dock appears to be through Dock's SH2 domain.

View larger version (47K):
[in this window]
[in a new window]
|
Fig. 3.
In vivo and in vitro
analyses of Dock's association with DSH3PX1. A,
Dock associates with DSH3PX1 in S2 cells. Dock and DSH3PX1
immunoprecipitates (IP) from S2 cell extracts were analyzed
by Western blotting using DSH3PX1 antibodies. An arrow
indicates DSH3PX1. B, Dock immunoprecipitates concentrate
the tyrosine-phosphorylated form of DSH3PX1. Dock and DSH3PX1
immunoprecipitates from S2 cell extracts were analyzed by Western
blotting with Tyr(P) (pTyr) antibodies. An arrow
indicates DSH3PX1. C, in vitro analysis of the
ability of Dock GST fusions to interact with DSH3PX1. GST fusion
proteins of the indicated Dock domains prepared in bacteria were mixed
with extracts prepared from S2 cells. The ability of the GST fusion
proteins to bind DSH3PX1 was assessed by Western analysis using
affinity-purified antibodies directed against DSH3PX1. The amount of
Dock GST fusion proteins present in each reaction is indicated in the
Coomassie-stained panel.
|
|
DSH3PX1 Is Present in a Complex with Dscam and the Clathrin Coat
Adaptor Protein, AP-50--
Since DSH3PX1 resembles a sorting nexin,
we sought to determine if it is capable of interacting with Dscam and,
if so, whether the interaction is dependent upon the presence of Dock.
Other sorting nexins have been shown to be associated with specific subsets of cell surface receptors (9). In untreated S2 cell extract
(UT), DSH3PX1 immunoprecipitates with Dscam antiserum (Fig.
4A). Using RNAi to abrogate
the expression of DSH3PX1 (DSH3PX1i) verifies that the protein with an
apparent molecular mass of 63 is indeed DSH3PX1 (26). Using
double-stranded RNA to eliminate Dock expression (Docki) had
no effect on the association between DSH3PX1 and Dscam (Fig.
4A). These results suggest that Dock is not a bridging
molecule required for Dscam's association with DSH3PX1.

View larger version (18K):
[in this window]
[in a new window]
|
Fig. 4.
DSH3PX1 associates with Dscam and the
clathrin adaptor protein, AP50. A, DSH3PX1
co-immunoprecipitates with Dscam in the absence of Dock. S2 extracts
(UT) or S2 extracts depleted of DSH3PX1
(DSH3PX1i) or Dock (Docki) were
immunoprecipitated (IP) with affinity-purified antibody
against the Dscam intracellular domain. The presence of DSH3PX1 was
detected by Western analysis using DSH3PX1 antibody. B,
DSH3PX1 co-immunoprecipitates with AP50. Extract was prepared from S2
cells stably expressing AP50 with a V5 tag. AP50 was immunoprecipitated
with V5 antibodies, and the presence of DSH3PX1 was detected by Western
analysis using affinity-purified DSH3PX1 antibody.
|
|
Cell surface receptors are also commonly endocytosed in clathrin-coated
vesicles and targeted for either degradation or recycling to the plasma
membrane (23, 34). The clathrin adaptor protein, AP-50, is a member of
the AP-2 complex that recognizes proteins destined for internalization
in clathrin-coated vesicles (35). We therefore sought to determine if
DSH3PX1 is in a complex with AP-50. Stably introducing a V5
epitope-tagged AP-50 construct into S2 cells, followed by
immunoprecipitation with V5 antiserum, verifies the association of
DSH3PX1 with AP-50 (Fig. 4B). To date, we have been unable
to demonstrate that Dscam will co-immunoprecipitate with antibodies
directed against AP-50. This suggests that DSH3PX1 could play an
important role in bridging cell surface receptors with proteins in
clathrin-coated vesicles.
DSH3PX1 Interacts with Proteins Involved in Cytoskeletal
Rearrangements--
We are interested in the mechanisms by which Dscam
could transduce signals leading to cytoskeletal rearrangements
necessary for axonal extension along a distinct trajectory. Since Dscam exists in a complex with DSH3PX1, we reasoned that studying the protein-protein interactions of DSH3PX1 would lend insight into the
downstream effectors of Dscam's signal transduction. To identify proteins that interact with DSH3PX1, we conducted a yeast two-hybrid screen of a third instar Drosophila library using
full-length DSH3PX1 as the bait. 12 of the 34 interacting clones
represented DSH3PX1 itself. This interaction was not dependent upon its
SH3 or PX domains, suggesting that DSH3PX1 contains a dimerization domain in its COOH terminus. Analysis of DSH3PX1 sequence using the
Coils program indicates a high probability of the COOH-terminal 20 amino acids forming a coiled-coil structure that could promote dimerization or the formation of higher order multimers (31). Other
two-hybrid positives included Wasp, a known regulator of the actin
cytoskeleton that is also involved in the process of endocytosis
(36).
Our two-hybrid library plasmid for Wasp contained sequences coding for
the COOH-terminal two-thirds of the protein, which includes the
GBD/CRIB, proline-rich, verpolin homology, and cofilin homology
domains. To obtain the full-length sequence for Drosophila Wasp, two additional expressed sequence tags, LP11964 and GH10436, were
sequenced in their entirety. During the preparation of this manuscript,
a sequence identical to ours for Drosophila Wasp was reported (37). The protein is 527 amino acids in length and contains
the same domain organization as its mammalian counterpart (Fig. 6),
namely an amino-terminal pleckstrin homology domain that binds
phospholipids, an IQ domain that mediates calcium binding, a CRIB
domain that binds Rac and Cdc42, a proline-rich region, two verpolin
homology domains, and a cofilin homology domain (14). The proline-rich
sequences of mammalian Wasp have been shown to bind a number of
different SH3 domain-containing proteins including Nck (38). Our
two-hybrid results indicate that DSH3PX1 interacts with Wasp via its
SH3 domain (Table I). To verify our
two-hybrid result, we demonstrated that in S2 cells stably expressing
Wasp engineered to contain a COOH-terminal V5-tag, DSH3PX1
co-immunoprecipitates with Wasp (Fig. 5,
left panel). As expected, this
co-immunoprecipitation is abolished in extracts prepared from cells
exposed to double-stranded RNA for DSH3PX1 (DSH3PX1i). In
cells that lack Dock (Docki), DSH3PX1 co-immunoprecipitates
with Wasp as effectively as in untreated cells. Dock also
immunoprecipitates the same amount of DSH3PX1 in the presence
(UT) or absence of Wasp (Waspi) in these cell extracts (Fig. 5, right panel). Therefore, there
is no competition for DSH3PX1 between these two binding partners,
suggesting that Dock is interacting with DSH3PX1 via a phosphorylated
tyrosine residue, while Wasp is interacting with DSH3PX1 via its SH3
domain. Anti-Tyr(P) Western analysis of Wasp immunoprecipitates
indicates that DSH3PX1 is not tyrosine-phosphorylated when associated
with Wasp (data not shown).

View larger version (60K):
[in this window]
[in a new window]
|
Fig. 5.
Different pools of DSH3PX1 associate with
Dock and Wasp. Extracts were prepared from S2 cells stably
expressing Wasp with a COOH-terminal V5 tag. Untreated extracts
(UT) or extracts depleted of the indicated proteins
(Waspi, DSH3PX1i, or Docki) were
immunoprecipitated (IP) with antibodies against Dock or V5
(Wasp). The presence of DSH3PX1 was detected by Western analysis using
affinity-purified DSH3PX1 antibody.
|
|
Protein-Protein Interactions among Dock, DSH3PX1, Wasp, and
Dscam--
We are interested in deciphering the protein-protein
interactions among DSH3PX1, Dock, Wasp, and Dscam to further understand how these proteins contribute to directed growth cone motility. The
results of a directed two-hybrid screen to address these interactions are shown in Table I. A full-length Dock bait is able to interact with
Wasp and Dscam (Table I). This is consistent with previously published
results demonstrating the interaction between Dock-SH3.1-3 domains and
proline-rich sequences in Dscam (6) and with the data demonstrating
that mammalian Nck will interact with mammalian Wasp (18, 38). In
agreement with Rohatgi et al. (18), in vitro
pull-down assays using GST fusions of Dock's SH3 domains indicate that
Drosophila Wasp does not interact with the Dock-SH3.1 or
SH3.3 domains but does interact weakly with the Dock-SH3.2 domain and
strongly with the fusion protein containing all three of Dock's SH3
domains (data not shown). In addition, Dock can bind to truncated forms
of DSH3PX1 ( 136) that do not contain the SH3 domain or the first
PXXP motif. However, further truncation of the sequence to
amino acid 361 ( 361) abolishes binding, suggesting that one or more
of Dock's SH3 domains can interact with sequences spanning amino acids
136-361. This region includes the PX domain that contains DSH3PX1's
second PXXP motif. It is interesting that Dock cannot
interact with full-length DSH3PX1, suggesting that DSH3PX1 may be in a
conformation in which the second PXXP motif is unavailable
for interaction with other SH3 domains. Full-length DSH3PX1 interacts
with Wasp via its SH3 domain as well as with all truncated versions of
itself presumably via the CC region. As indicated by the qualitative
assessment of -galactosidase activity, DSH3PX1's SH3 domain
interacts more strongly with Wasp's proline-rich sequences than with
Dscam's proline-rich sequences or with its own sequences spanning
amino acids 136-361. As expected, the COOH-terminal bait construct for
DSH3PX1 interacts with versions of itself, all of which contain the CC
region. Taken together, these results suggest that DSH3PX1 exists as a
dimer or multimer whose SH3 domain strongly interacts with Wasp. There
is also a growing body of evidence that suggests that PX domains bind
phosphatidylinositol 3-phosphate and phosphatidylinositol
3,4-bisphosphate (12, 39). Likewise, recent studies reviewed by Wishart
et al. (13) speculate that the availability of the PX domain
to bind lipid can be controlled by an intramolecular interaction
between the SH3 domain and a PXXP motif found within the PX
domain. This raises the intriguing possibility that DSH3PX1's
protein-protein interactions could be regulated by an intramolecular
interaction between its SH3 domain and the PXXP motif
present in its PX domain. Finally, it is clear that an unspecified
tyrosine kinase can phosphorylate DSH3PX1 and that modification
modulates its interaction with Dock. Possible DSH3PX1 protein and lipid
interactions are summarized in Fig.
6.

View larger version (34K):
[in this window]
[in a new window]
|
Fig. 6.
DSH3PX1 protein and lipid interactions.
In the schematic representation of Dscam, blackened
ovals represent IgG repeats, while blackened
rectangles represent fibronectin repeats. The DSH3PX1
schematic consists of an SH3 domain (shaded gray)
and a PX domain (shaded black). The penultimate
20 amino acids are predicted to form a coiled-coil (CC,
clear box). The schematic of Dock contains three
SH3 domains, as indicated, and an SH2 domain represented by a
blackened oval. In the schematic of
Drosophila Wasp, the phospholipid-binding domain
(PH) is represented by a stippled
oval, the Ca2+ binding domain (IQ) is
represented as a blackened box, and the
Cdc42-binding domain (GBD/CRIB) is depicted by a
clear oval. The proline-rich sequence is
represented by a box, and the verpolin (VH) and
cofilin (CH) binding domains are depicted by
stippled hexagons and a blackened
oval, respectively. All domain predictions were made using
the SMART program (52). The arrows indicate interactions
between protein and lipids present in this complex, and
arrows with question marks indicate
interactions that may not be direct. In the case of the Dock-Dscam
interaction, all three Dock SH3 domains are known to interact with
several PXXP motifs present in Dscam (6). In addition,
Dock's SH2 domain is capable of interacting with
tyrosine-phosphorylated Dscam (interaction not indicated).
Similarly, all three SH3 domains of Dock are required
for efficient interaction with Wasp as discussed in
Protein-Protein Interactions among Dock, DSH3PX1, Wasp, and
Dscam in "Results."
|
|
 |
DISCUSSION |
The most compelling evidence for the involvement of sorting nexins
in vesicular trafficking has been reported in yeast. For example,
Vps5p, the S. cerevisiae orthologue of SNX1, is a subunit of
the retromer complex and is involved in recycling the carboxypeptidase Y receptor from endosomes to the trans-Golgi network (40). The yeast
orthologue of SNX3, Grd19, maintains the localization of two late Golgi
enzymes, dipeptidyl amino peptidase A and Kex2, by retrieving molecules
from prevacuolar endosomes (41). Additionally, Mvp1p is believed to
participate in the formation of vesicles that facilitate vacuolar
protein targeting (42). In mammalian studies, SNX1 is involved in
regulating the endocytosis of ligand-activated epidermal growth factor
receptor (8), while SNX15 is involved in the internalization and
degradation of the platelet-derived growth factor receptor as well as
affecting the post-translational processing of the proreceptors for
insulin and hepatocyte growth factor (32). SNX2 and SNX4 have
been shown to associate with the platelet-derived growth factor
receptor, the insulin receptor, and the long isoform of the leptin
receptor as well as epidermal growth factor receptor but have yet to be
associated with increased receptor turnover (9). Therefore, there is a
strong correlation between PX domain-containing proteins and vesicular trafficking.
In this study, we have identified a novel Drosophila sorting
nexin, DSH3PX1, and determined that tyrosine-phosphorylated DSH3PX1 interacts with the SH2 domain of the axon guidance adaptor protein Dock. We have further characterized its protein-protein interactions by
co-immunoprecipitation, in vitro pull-down, and two-hybrid analyses. Our results link the axon guidance receptor Dscam to DSH3PX1,
AP-50, and Wasp proteins that may form part of the machinery necessary
for receptor internalization and sorting (Fig. 6).
As discussed previously, DSH3PX1 is abundantly expressed in S2 cells,
but only a small fraction of the protein is tyrosine-phosphorylated. Increased levels of DSH3PX1 tyrosine phosphorylation can be generated in response to overexpression of the Dock-SH2 domain or vanadate treatment (data not shown). Moreover, most of the
tyrosine-phosphorylated DSH3PX1 can be immunoprecipitated with Dock
antibodies, indicating that tyrosine phosphorylation may target DSH3PX1
to a new cellular program involving the Dock-Dscam receptor
complex. Presumably, the remaining pool of unphosphorylated DSH3PX1 is
involved in other cellular activities. Given the association of DSH3PX1
with Dscam and Dock, a potential role for DSH3PX1 in axon guidance was
examined in Drosophila embryos using RNAi. Unfortunately, pleiotropic effects were observed in knockout embryos that disrupted the development of head structures and made assessment of axon guidance
defects impossible to score.2
Therefore, any role for DSH3PX1 in vesicular trafficking is likely to
be more global than merely regulating the presentation of the Dscam
receptor on the plasma membrane of growth cones to control axon guidance.
Since DSH3PX1 can be co-immunoprecipitated with Dscam and AP-50, it is
tempting to speculate that this molecule is involved in sorting Dscam
from the plasma membrane via clathrin-coated pits to other cellular
compartments that destine it either for recycling or degradation. Since
neither Dscam nor AP-50 was represented as positive in our two-hybrid
screen, it is possible that these interactions are not direct but rely
on bridging molecules (Fig. 6). We have started to address this
question by the removal of potential bridging partners from the cells
using RNAi technology (26). By the removal of Dock from the S2 cells,
we can show that the co-immunoprecipitation of DSH3PX1 with Dscam does
not depend upon the presence of this protein. Additional experiments of
this type will have to be performed using combinations of
double-stranded RNAs to decipher the important protein-protein
interactions maintaining this complex of proteins surrounding the Dscam receptor.
It seems reasonable that one of the ways a growth cone could direct its
growth would be to cycle guidance receptors to and from its plasma
membrane to sample the surrounding environment for directional cues. In
this scenario, the appearance of guidance receptors on the plasma
membrane and their timely removal after ligand stimulation would be of
critical importance to directing growth. Wasp, one of our two-hybrid
positives, could be instrumental in effecting the cytoskeletal changes
necessary for endocytosis or growth cone remodeling. Wasp is a
multidomain protein whose COOH terminus contains verpolin and cofilin
homology domains (14). These domains act in concert with the
Arp2/3 complex to polymerize globular actin into filaments (43).
Wasp can be activated by binding GTP-Cdc42 or by interactions of
specific SH3 domains with its proline-rich sequences. The proline-rich
sequences in mammalian Wasp have been shown to bind a large number of
SH3 domain-containing proteins including Nck (18). In S2 cells, Dock's
SH3 domains are known to interact with Dscam, DPTP61F, and Pak (6, 44, 45). All three SH3 domains interact with Dscam, while the SH3.2 domain
interacts with DPTP61F or Pak. In in vitro pull-down assays, all three SH3 domains interact with Wasp (data not shown), while SH3.3
interacts with DSH3PX1. It is interesting to speculate that depending
upon the intracellular signaling environment Wasp, Dock, and SH3PX1 may
be involved in different protein-protein interactions and therefore in
different aspects of actin cytoskeletal regulation.
Until recently, Wasp's role in endocytosis was not appreciated. In
mammalian cells, it was reported that actin-binding proteins such as
DNase I and thymosin B4 or drugs such as latrunculin A, which
selectively sequester actin monomers, inhibit the formation of
clathrin-coated vesicles at the plasma membrane (46). Furthermore, it
has been suggested that N-Wasp participates in vesicle transport at
nerve endings by transmitting signals from tyrosine kinases to cortical
actin filaments (17). This view is supported by immunostaining and
tissue fractionation studies, showing that N-Wasp is concentrated at
nerve endings (17). Taken together, it seems likely that Wasp in
conjunction with a sorting nexin could play a variety of roles in the
growth cone depending upon the signaling milieu.
The sorting nexin family is defined by the presence of a PX domain, a
domain that was originally discovered in proteins involved in the
regulation of NADPH oxidase and is also found in a subset of
phosphatidylinositol 3-kinases, Saccharomyces
cerevisiae Bem1p, and Schizosaccharomyces pombe
Scd2 (10). The PX domain commonly contains a proline-rich sequence that
could potentially bind an SH3 domain. In the case of the PX
domain-containing proteins involved in the regulation of NADPH oxidase,
p47phox and p67phox, the SH3 domain-mediated
interactions are regulated. p47phox contains two SH3 domains
and an SH3 domain target sequence in addition to a PX domain. In both
cases, a proposed conversion from intramolecular interactions to
intermolecular SH3-polyproline interactions occurs in response to
extracellular signals to up-regulate NADPH oxidase activity (47). The
SH3 domain of DSH3PX1 is also capable of interactions involving
sequences that span its PX domain. It is intriguing that Dock cannot
interact with full-length DSH3PX1, raising the possibility that
DSH3PX1's protein-protein interactions may be hindered by an
intramolecular interaction.
Mammalian SH3PX1 (also known as SNX9) has been identified through a
two-hybrid screen using the intracellular portions of the
metalloprotease disintegrins, MDC9 or MDC15, as the baits (33). These
metalloproteases are part of a family of membrane-anchored glycoproteins (ADAMS) that function among other things in neurogenesis, myogenesis, and ectodomain processing of cytokines and other proteins (48-51). These proteases also interact with endophilin I, which is
thought to play a role in synaptic vesicle endocytosis (33). The fact
that DSH3PX1 interacts with Dscam as well as MDC9 and MDC15 could imply
that the sorting nexin has the ability to interact with numerous cell
surface receptors.
In summary, we have characterized the intra- and intermolecular
interactions of DSH3PX1. This is the first report of a
tyrosine-phosphorylated sorting nexin, a modification that most likely
transforms DSH3PX1 into a binding partner for Dock. We extend this
complex to contain Dscam, AP-50, and Wasp. DSH3PX1's ability to
interact with Wasp and AP-50 links clathrin-coated pits to the
actin cytoskeleton, suggesting that one of DSH3PX1's roles may be to
serve as a sorting nexin for the Dscam axon guidance receptor.
 |
ACKNOWLEDGEMENTS |
We thank K. Orth and M. Wishart for critical
reading of the manuscript and M. Nagara and M. Wishart for expert
artistic input.
 |
FOOTNOTES |
*
This work was supported by National Institutes of Health
Grant 18024 (to J. E. D.), the Walther Cancer Institute (to
J. E. D., C. A. W., and M. M.), and the Human Frontier Science
Program (to M. M.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
Present address: Howard Hughes Medical Institute, Dept. of
Biological Chemistry, UCLA School of Medicine, Los Angeles, CA 90095.
§
Present address: Serono Reproductive Biology Institute, Inc.,
Randolph, MA 02368.
¶
To whom correspondence should be addressed. Tel.:
734-647-3998; Fax: 734-763-4581; E-mail: jedixon@umich.edu.
Published, JBC Papers in Press, September 6, 2001, DOI 10.1074/jbc.M107080200
2
J. C. Clemens, personal communication.
 |
ABBREVIATIONS |
The abbreviations used are:
SH3, Src homology 3;
SH2, Src homology 2;
PX, PHOX homology;
RIPA, radioimmune precipitation
assay;
RNAi, RNA Interference.
 |
REFERENCES |
| 1.
|
Tessier-Lavigne, M.,
and Goodman, C. S.
(1996)
Science
274,
1123-1133[Abstract/Free Full Text]
|
| 2.
|
Kamiguchi, H.,
and Lemmon, V.
(2000)
Curr. Opin. Cell Biol.
12,
598-605[CrossRef][Medline]
[Order article via Infotrieve]
|
| 3.
|
Kamiguchi, H.,
and Lemmon, V.
(2000)
J. Neurosci.
20,
3676-3686[Abstract/Free Full Text]
|
| 4.
|
Chisholm, A.,
and Tessier-Lavigne, M.
(1999)
Curr. Opin. Neurobiol.
9,
603-615[CrossRef][Medline]
[Order article via Infotrieve]
|
| 5.
|
Garrity, P. A.,
Rao, Y.,
Salecker, I.,
McGlade, J.,
Pawson, T.,
and Zipursky, S. L.
(1996)
Cell
85,
639-650[CrossRef][Medline]
[Order article via Infotrieve]
|
| 6.
|
Schmucker, D.,
Clemens, J. C.,
Shu, H.,
Worby, C. A.,
Xiao, J.,
Muda, M.,
Dixon, J. E.,
and Zipursky, S. L.
(2000)
Cell
101,
671-684[CrossRef][Medline]
[Order article via Infotrieve]
|
| 7.
|
Parks, W.,
Frank, D.,
Huff, C.,
Renfrew Haft, C.,
Martin, J.,
Meng, X.,
de Caestecker, M.,
McNally, J.,
Reddi, A.,
Taylor, S.,
Roberts, A.,
Wang, T.,
and Lechleider, R.
(2001)
J. Biol. Chem.
276,
19332-19339[Abstract/Free Full Text]
|
| 8.
|
Kurten, R. C.,
Cadena, D. L.,
and Gill, G. N.
(1996)
Science
272,
1008-1010[Abstract]
|
| 9.
|
Haft, C. R.,
de la Luz Sierra, M.,
Barr, V. A.,
Haft, D. H.,
and Taylor, S. I.
(1998)
Mol. Cell. Biol.
18,
7278-7287[Abstract/Free Full Text]
|
| 10.
|
Ponting, C. P.
(1996)
Protein Sci.
5,
2353-2357[Medline]
[Order article via Infotrieve]
|
| 11.
|
Hiroaki, H.,
Ago, T.,
Ito, T.,
Sumimoto, H.,
and Kohda, D.
(2001)
Nat. Struct. Biol.
8,
526-530[CrossRef][Medline]
[Order article via Infotrieve]
|
| 12.
|
Xu, Y.,
Hortsman, H.,
Seet, L.,
Wong, S.,
and Hong, W.
(2001)
Nat. Cell Biol.
3,
658-666[CrossRef][Medline]
[Order article via Infotrieve]
|
| 13.
|
Wishart, M.,
Taylor, G.,
and Dixon, J.
(2001)
Cell
105,
817-820[CrossRef][Medline]
[Order article via Infotrieve]
|
| 14.
|
Zigmond, S. H.
(2000)
J. Cell Biol.
150,
F117-F120
|
| 15.
|
Higgs, H. N.,
Blanchoin, L.,
and Pollard, T. D.
(1999)
Biochemistry
38,
15212-15222[CrossRef][Medline]
[Order article via Infotrieve]
|
| 16.
|
Higgs, H. N.,
and Pollard, T. D.
(1999)
J. Biol. Chem.
274,
32531-32534[Free Full Text]
|
| 17.
|
Miki, H.,
Miura, K.,
and Takenawa, T.
(1996)
EMBO J.
15,
5326-5335[Medline]
[Order article via Infotrieve]
|
| 18.
|
Rohatgi, R.,
Nollau, P.,
Ho, H.,
Kirschner, M.,
and Mayer, B.
(2001)
J. Biol. Chem.
276,
26448-26452[Abstract/Free Full Text]
|
| 19.
|
Banzai, Y.,
Miki, H.,
Yamaguchi, H.,
and Takenawa, T.
(2000)
J. Biol. Chem.
275,
11987-11992[Abstract/Free Full Text]
|
| 20.
|
Munn, A.
(2001)
Biochim. Biophys. Acta
1535,
236-257[Medline]
[Order article via Infotrieve]
|
| 21.
|
She, H. Y.,
Rockow, S.,
Tang, J.,
Nishimura, R.,
Skolnik, E. Y.,
Chen, M.,
Margolis, B.,
and Li, W.
(1997)
Mol. Biol. Cell
8,
1709-1721[Abstract]
|
| 22.
|
Snapper, S. B.,
Rosen, F. S.,
Mizoguchi, E.,
Cohen, P.,
Khan, W.,
Liu, C. H.,
Hagemann, T. L.,
Kwan, S. P.,
Ferrini, R.,
Davidson, L.,
Bhan, A. K.,
and Alt, F. W.
(1998)
Immunity
9,
81-91[CrossRef][Medline]
[Order article via Infotrieve]
|
| 23.
|
Brodin, L.,
Low, P.,
and Shupliakov, O.
(2000)
Curr. Opin. Neurobiol.
10,
312-320[CrossRef][Medline]
[Order article via Infotrieve]
|
| 24.
|
Hirst, J.,
and Robinson, M. S.
(1998)
Biochim. Biophys. Acta
1404,
173-193[Medline]
[Order article via Infotrieve]
|
| 25.
|
Zhang, Y. Q.,
and Broadie, K.
(1999)
Gene (Amst.)
233,
171-179[CrossRef][Medline]
[Order article via Infotrieve]
|
| 26.
|
Clemens, J. C.,
Worby, C. A.,
Simonson-Leff, N.,
Muda, M.,
Maehama, T.,
Hemmings, B. A.,
and Dixon, J. E.
(2000)
Proc. Natl. Acad. Sci. U. S. A.
97,
6499-6503[Abstract/Free Full Text]
|
| 27.
| Worby, C. A., Simonson-Leff, N., and Dixon, J. (2001) Science's
STKE,
http://stke.sciencemag.org/cgi/content/full/OC_sigtrans;2001/95/pl1
|
| 28.
|
Worby, C. A.,
Clemens, J.,
and Dixon, J.
(1997)
in
Cell Biology: A Laboratory Manual
(Spector, D. L.
, Goldman, R. D.
, and Leinwald, L. A., eds)
, pp. 1-10, Cold Spring Harbor Press, Cold Spring Harbor, NY
|
| 29.
|
Durfee, T.,
Becherer, K.,
Chen, P. L.,
Yeh, S. H.,
Yang, Y.,
Kilburn, A. E.,
Lee, W. H.,
and Elledge, S. J.
(1993)
Genes Dev.
7,
555-569[Abstract/Free Full Text]
|
| 30.
|
Vojtek, A. B.,
and Hollenberg, S. M.
(1995)
Methods Enzymol.
255,
331-342[Medline]
[Order article via Infotrieve]
|
| 31.
|
Lupas, A.,
Van Dyke, M.,
and Stock, J.
(1991)
Science
252,
1162-1164[Free Full Text]
|
| 32.
|
Barr, V. A.,
Phillips, S. A.,
Taylor, S. I.,
and Haft, C. R.
(2000)
Traffic
1,
904-916[CrossRef][Medline]
[Order article via Infotrieve]
|
| 33.
|
Howard, L.,
Nelson, K. K.,
Maciewicz, R. A.,
and Blobel, C. P.
(1999)
J. Biol. Chem.
274,
31693-31699[Abstract/Free Full Text]
|
| 34.
|
Slepnev, V. I.,
and De Camilli, P.
(2000)
Nat. Rev. Neurosci.
1,
161-172[Medline]
[Order article via Infotrieve]
|
| 35.
|
Zhang, Y.,
and Allison, J. P.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
9273-9278[Abstract/Free Full Text]
|
| 36.
|
Qualmann, B.,
and Kelly, R. B.
(2000)
J. Cell Biol.
148,
1047-1062[Abstract/Free Full Text]
|
| 37.
|
Ben-Yaacov, S.,
Le Borgne, R.,
Abramson, I.,
Schweisguth, F.,
and Schejter, E. D.
(2001)
J. Cell Biol.
152,
1-13[Abstract/Free Full Text]
|
| 38.
|
Rivero-Lezcano, O. M.,
Marcilla, A.,
Sameshima, J. H.,
and Robbins, K. C.
(1995)
Mol. Cell. Biol.
15,
5725-5731[Abstract]
|
| 39.
|
Kanai, F.,
Liu, H.,
Field, S.,
Akbary, H.,
Matsuo, T.,
Brown, G.,
Cantley, L.,
and Yaffe, M.
(2001)
Nat. Cell Biol.
3,
675-678[CrossRef][Medline]
[Order article via Infotrieve]
|
| 40.
|
Horazdovsky, B. F.,
Davies, B. A.,
Seaman, M. N.,
McLaughlin, S. A.,
Yoon, S.,
and Emr, S. D.
(1997)
Mol. Biol. Cell
8,
1529-1541[Abstract]
|
| 41.
|
Voos, W.,
and Stevens, T. H.
(1998)
J. Cell Biol.
140,
577-590[Abstract/Free Full Text]
|
| 42.
|
Ekena, K.,
and Stevens, T. H.
(1995)
Mol. Cell. Biol.
15,
1671-1678[Abstract]
|
| 43.
|
Higgs, H.,
and TD, P.
(2001)
Annu. Rev. Biochem.
70,
649-676[CrossRef][Medline]
[Order article via Infotrieve]
|
| 44.
|
Hing, H.,
Xiao, J.,
Harden, N.,
Lim, L.,
and Zipursky, S. L.
(1999)
Cell
97,
853-863[CrossRef][Medline]
[Order article via Infotrieve]
|
| 45.
|
Clemens, J. C.,
Ursuliak, Z.,
Clemens, K. K.,
Price, J. V.,
and Dixon, J. E.
(1996)
J. Biol. Chem.
271,
17002-17005[Abstract/Free Full Text]
|
| 46.
|
Lamaze, C.,
Fujimoto, L. M.,
Yin, H. L.,
and Schmid, S. L.
(1997)
J. Biol. Chem.
272,
20332-20335[Abstract/Free Full Text]
|
| 47.
|
Ahmed, S.,
Prigmore, E.,
Govind, S.,
Veryard, C.,
Kozma, R.,
Wientjes, F. B.,
Segal, A. W.,
and Lim, L.
(1998)
J. Biol. Chem.
273,
15693-15701[Abstract/Free Full Text]
|
| 48.
|
Qi, H.,
Rand, M. D.,
Wu, X.,
Sestan, N.,
Wang, W.,
Rakic, P.,
Xu, T.,
and Artavanis-Tsakonas, S.
(1999)
Science
283,
91-94[Abstract/Free Full Text]
|
| 49.
|
Gutwein, P.,
Oleszewski, M.,
Mechtersheimer, S.,
Agmon-Levin, N.,
Krauss, K.,
and Altevogt, P.
(2000)
J. Biol. Chem.
275,
15490-15497[Abstract/Free Full Text]
|
| 50.
|
Galko, M. J.,
and Tessier-Lavigne, M.
(2000)
Science
289,
1365-1367[Abstract/Free Full Text]
|
| 51.
|
Peschon, J. J.,
Slack, J. L.,
Reddy, P.,
Stocking, K. L.,
Sunnarborg, S. W.,
Lee, D. C.,
Russell, W. E.,
Castner, B. J.,
Johnson, R. S.,
Fitzner, J. N.,
Boyce, R. W.,
Nelson, N.,
Kozlosky, C. J.,
Wolfson, M. F.,
Rauch, C. T.,
Cerretti, D. P.,
Paxton, R. J.,
March, C. J.,
and Black, R. A.
(1998)
Science
282,
1281-1284[Abstract/Free Full Text]
|
| 52.
|
Schultz, J.,
Milpetz, F.,
Bork, P.,
and Ponting, C. P.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
5857-5864[Abstract/Free Full Text]
|
Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
R. Lundmark and S. R. Carlsson
SNX9 - a prelude to vesicle release
J. Cell Sci.,
January 1, 2009;
122(1):
5 - 11.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Schobel, S. Neumann, M. Hertweck, B. Dislich, P.-H. Kuhn, E. Kremmer, B. Seed, R. Baumeister, C. Haass, and S. F. Lichtenthaler
A Novel Sorting Nexin Modulates Endocytic Trafficking and {alpha}-Secretase Cleavage of the Amyloid Precursor Protein
J. Biol. Chem.,
May 23, 2008;
283(21):
14257 - 14268.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Shin, N. Ahn, B. Chang-Ileto, J. Park, K. Takei, S.-G. Ahn, S.-A Kim, G. Di Paolo, and S. Chang
SNX9 regulates tubular invagination of the plasma membrane through interaction with actin cytoskeleton and dynamin 2
J. Cell Sci.,
April 15, 2008;
121(8):
1252 - 1263.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Shin, S. Lee, N. Ahn, S.-A Kim, S.-G. Ahn, Z. YongPark, and S. Chang
Sorting Nexin 9 Interacts with Dynamin 1 and N-WASP and Coordinates Synaptic Vesicle Endocytosis
J. Biol. Chem.,
September 28, 2007;
282(39):
28939 - 28950.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. M. Alto, A. W. Weflen, M. J. Rardin, D. Yarar, C. S. Lazar, R. Tonikian, A. Koller, S. S. Taylor, C. Boone, S. S. Sidhu, et al.
The type III effector EspF coordinates membrane trafficking by the spatiotemporal activation of two eukaryotic signaling pathways
J. Cell Biol.,
September 24, 2007;
178(7):
1265 - 1278.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Q. Zhong, M. J. Watson, C. S. Lazar, A. M. Hounslow, J. P. Waltho, and G. N. Gill
Determinants of the Endosomal Localization of Sorting Nexin 1
Mol. Biol. Cell,
April 1, 2005;
16(4):
2049 - 2057.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Soulet, D. Yarar, M. Leonard, and S. L. Schmid
SNX9 Regulates Dynamin Assembly and Is Required for Efficient Clathrin-mediated Endocytosis
Mol. Biol. Cell,
April 1, 2005;
16(4):
2058 - 2067.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Lundmark and S. R. Carlsson
Regulated Membrane Recruitment of Dynamin-2 Mediated by Sorting Nexin 9
J. Biol. Chem.,
October 8, 2004;
279(41):
42694 - 42702.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. D. X. Chuong, A. G. Good, G. J. Taylor, M. C. Freeman, G. B. G. Moorhead, and D. G. Muench
Large-scale Identification of Tubulin-binding Proteins Provides Insight on Subcellular Trafficking, Metabolic Channeling, and Signaling in Plant Cells
Mol. Cell. Proteomics,
October 1, 2004;
3(10):
970 - 983.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Li and K.-L. Guan
The Down Syndrome Cell Adhesion Molecule (DSCAM) Interacts with and Activates Pak
J. Biol. Chem.,
July 30, 2004;
279(31):
32824 - 32831.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Lundmark and S. R. Carlsson
Sorting Nexin 9 Participates in Clathrin-mediated Endocytosis through Interactions with the Core Components
J. Biol. Chem.,
November 21, 2003;
278(47):
46772 - 46781.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. A. Worby, N. Simonson-Leff, J. C. Clemens, D. Huddler Jr., M. Muda, and J. E. Dixon
Drosophila Ack Targets Its Substrate, the Sorting Nexin DSH3PX1, to a Protein Complex Involved in Axonal Guidance
J. Biol. Chem.,
March 8, 2002;
277(11):
9422 - 9428.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|